Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Using HER2-PET to Predict the Efficacy of T-DXd Treatment in Advanced Breast Cancer and to Investigate the Heterogeneity of HER2 Expression

NCT07586215 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07586215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07586215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Using HER2-PET to Predict the Efficacy of T-DXd Treatment in Advanced Breast Cancer and to Investigate the Heterogeneity of HER2 Expression
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
November 11, 2024
Completion date
December 11, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic